Canada Life’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.1M | Buy |
35,536
+440
| +1% | +$219K | 0.04% | 354 |
|
|
2025
Q4 | $17.1M | Sell |
35,096
-32,061
| -48% | -$14.9M | 0.03% | 413 |
|
|
2025
Q3 | $28.5M | Sell |
67,157
-1,412
| -2% | -$475K | 0.04% | 348 |
|
|
2025
Q2 | $19.7M | Sell |
68,569
-12,159
| -15% | -$3.63M | 0.03% | 423 |
|
|
2025
Q1 | $24.9M | Buy |
80,728
+10,339
| +15% | +$3.54M | 0.04% | 362 |
|
|
2024
Q4 | $24.8M | Buy |
70,389
+4,110
| +6% | +$1.51M | 0.04% | 355 |
|
|
2024
Q3 | $23.8M | Buy |
66,279
+944
| +1% | +$319K | 0.04% | 376 |
|
|
2024
Q2 | $20.8M | Buy |
65,335
+9,671
| +17% | +$2.56M | 0.04% | 384 |
|
|
2024
Q1 | $12.8M | Sell |
55,664
-3,219
| -5% | -$726K | 0.03% | 505 |
|
|
2023
Q4 | $12.9M | Sell |
58,883
-12,020
| -17% | -$2.77M | 0.03% | 490 |
|
|
2023
Q3 | $16M | Buy |
70,903
+5,760
| +9% | +$1.33M | 0.04% | 420 |
|
|
2023
Q2 | $14.4M | Buy |
65,143
+21,878
| +51% | +$4.85M | 0.03% | 445 |
|
|
2023
Q1 | $9.69M | Buy |
43,265
+4,064
| +10% | +$1M | 0.02% | 539 |
|
|
2022
Q4 | $10.9M | Buy |
39,201
+5,386
| +16% | +$1.36M | 0.03% | 500 |
|
|
2022
Q3 | $7.07M | Buy |
33,815
+1,377
| +4% | +$308K | 0.02% | 581 |
|
|
2022
Q2 | $7.65M | Buy |
32,438
+4,112
| +15% | +$836K | 0.02% | 592 |
|
|
2022
Q1 | $5.24M | Buy |
28,326
+2,320
| +9% | +$442K | 0.01% | 745 |
|
|
2021
Q4 | $5.61M | Buy |
26,006
+1,555
| +6% | +$305K | 0.01% | 717 |
|
|
2021
Q3 | $4.55M | Buy |
24,451
+6,185
| +34% | +$1.22M | 0.01% | 748 |
|
|
2021
Q2 | $3.28M | Sell |
18,266
-3,538
| -16% | -$674K | 0.01% | 854 |
|
|
2021
Q1 | $3.64M | Sell |
21,804
-1,705
| -7% | -$284K | 0.01% | 805 |
|
|
2020
Q4 | $3.56M | Buy |
23,509
+1,749
| +8% | +$230K | 0.01% | 869 |
|
|
2020
Q3 | $2.2M | Sell |
21,760
-207
| -0.9% | -$22.7K | ﹤0.01% | 1017 |
|
|
2020
Q2 | $2.65M | Sell |
21,967
-955
| -4% | -$107K | 0.01% | 941 |
|
|
2020
Q1 | $2.18M | Buy |
22,922
+1,439
| +7% | +$137K | 0.01% | 904 |
|
|
2019
Q4 | $1.88M | Buy |
+21,483
| New | +$1.89M | ﹤0.01% | 1166 |
|
|
2019
Q3 | – | Sell |
-26,229
| Closed | -$2.05M | – | 2232 |
|
|
2019
Q2 | $2.05M | Sell |
26,229
-74,904
| -74% | -$7M | ﹤0.01% | 1169 |
|
|
2019
Q1 | $11.8M | Buy |
101,133
+3,757
| +4% | +$438K | 0.03% | 450 |
|
|
2018
Q4 | $10M | Sell |
97,376
-14,989
| -13% | -$1.74M | 0.03% | 460 |
|
|
2018
Q3 | $14.4M | Sell |
112,365
-6,610
| -6% | -$818K | 0.03% | 412 |
|
|
2018
Q2 | $13.5M | Buy |
118,975
+10,941
| +10% | +$1.2M | 0.03% | 442 |
|
|
2018
Q1 | $12.1M | Buy |
108,034
+4,422
| +4% | +$562K | 0.03% | 462 |
|
|
2017
Q4 | $15.3M | Sell |
103,612
-25,956
| -20% | -$3.3M | 0.04% | 415 |
|
|
2017
Q3 | $15.4M | Buy |
129,568
+8,453
| +7% | +$1.08M | 0.04% | 403 |
|
|
2017
Q2 | $15.7M | Buy |
121,115
+9,948
| +9% | +$1.24M | 0.04% | 394 |
|
|
2017
Q1 | $15M | Buy |
111,167
+897
| +0.8% | +$136K | 0.04% | 403 |
|
|
2016
Q4 | $15.9M | Buy |
110,270
+25,767
| +30% | +$3.29M | 0.04% | 372 |
|
|
2016
Q3 | $9.97M | Buy |
84,503
+7,012
| +9% | +$843K | 0.03% | 486 |
|
|
2016
Q2 | $8.19M | Buy |
77,491
+64,892
| +515% | +$7.24M | 0.02% | 532 |
|
|
2016
Q1 | $1.4M | Sell |
12,599
-4,414
| -26% | -$559K | 0.01% | 776 |
|
|
2015
Q4 | $2.67M | Sell |
17,013
-2,836
| -14% | -$413K | 0.01% | 690 |
|
|
2015
Q3 | $2.6M | Buy |
19,849
+1,023
| +5% | +$164K | 0.01% | 685 |
|
|
2015
Q2 | $3.27M | Buy |
18,826
+537
| +3% | +$96.6K | 0.01% | 720 |
|
|
2015
Q1 | $3.14M | Sell |
18,289
-52,505
| -74% | -$8M | 0.01% | 725 |
|
|
2014
Q4 | $9.18M | Sell |
70,794
-3,157
| -4% | -$407K | 0.03% | 447 |
|
|
2014
Q3 | $9.51M | Sell |
73,951
-21,173
| -22% | -$2.18M | 0.03% | 436 |
|
|
2014
Q2 | $8.39M | Buy |
95,124
+800
| +0.8% | +$76.9K | 0.03% | 468 |
|
|
2014
Q1 | $8.83M | Sell |
94,324
-1,700
| -2% | -$174K | 0.03% | 435 |
|
|
2013
Q4 | $10.9M | Sell |
96,024
-6,900
| -7% | -$622K | 0.04% | 399 |
|
|
2013
Q3 | $8.11M | Buy |
102,924
+4,221
| +4% | +$309K | 0.03% | 434 |
|
|
2013
Q2 | $6.5M | Buy |
+98,703
| New | +$6.36M | 0.04% | 312 |
|
Other funds holding UTHR
ACA
VPM
VCM
Canada Life's UTHR Position: Q1 2026 in Review
Canada Life increased its United Therapeutics (UTHR) stake by 1.3% in Q1 2026, buying an estimated $219K and bringing the position to 35,536 shares worth $21.1M. The position accounts for 0.04% of the portfolio, ranked #354.
Canada Life first reported a position in UTHR in Q2 2013 and has held it in 51 quarters since. The position peaked at $28.5M in Q3 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Canada Life held 35,536 shares of United Therapeutics worth $21.1M as of Q1 2026.
- Canada Life bought 440 United Therapeutics shares in Q1 2026, an estimated $219K.
- United Therapeutics made up 0.04% of Canada Life's portfolio in Q1 2026, its #354 holding.
- Canada Life first reported a position in United Therapeutics in Q2 2013 and has held it in 51 quarters since.
- Canada Life's United Therapeutics position peaked at $28.5M in Q3 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.